Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus

被引：0
|
作者：
Ikonomidis, I. [1 ]
Katogiannis, K. [2 ]
Kountouri, A. [3 ]
Pavlidis, G. [2 ]
Thymis, J. [2 ]
Korakas, E. [2 ]
Kostelli, G. [2 ]
Katsanaki, E. [2 ]
Michalopoulou, E. [2 ]
Vlachomitros, D. [2 ]
Pliouta, L. [3 ]
Balampanis, K. [3 ]
Lambadiari, V [3 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Cardiol Dept 2, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Res Unit & Diabet Ctr, Dept Internal Med 2, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2924
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dapagliflozin Preserves Vascular Endothelial Function and Improves Glycemic Control in High CV Risk Patients with Type 2 Diabetes Mellitus: Edified Study
    Aisyah, Z. Nur
    Rohana, A. G.
    Faradilla, W. H. S.
    Fatimah, Z. M. S.
    Huda
    Zaliha
    Atikah, D. Nur
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 12 - 12
  • [22] Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
    Lunder, Mojca
    Janic, Miodrag
    Japelj, Miha
    Juretic, Andrej
    Janez, Andrej
    Sabovic, Miso
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [23] Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus
    Kovamees, Oskar
    Shemyakin, Alexey
    Checa, Antonio
    Wheelock, Craig E.
    Lundberg, Jon O.
    Ostenson, Claes-Goran
    Pernow, John
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (11) : 3952 - 3958
  • [24] Arterial Stiffness And Endothelial Function In Patients With Type 1 Diabetes Mellitus
    Kosobyan, Evgeniya
    Jarek-Martynowa, Iwona
    Yasamanova, Albina
    Parfenov, Aleksandr
    Shestakova, Marina
    DIABETES, 2012, 61 : A569 - A569
  • [25] The effect of the combined treatment with dulaglutide and dapagliflozin in arterial elasticity, cardiac function, albuminuria and endothelial thickness in type 2 diabetes mellitus after 12 months
    Ikonomidis, I.
    Thymis, J.
    Korakas, E.
    Kountouri, A.
    Pavlidis, G.
    Katogiannis, K.
    Pliouta, L.
    Raptis, A.
    Lambadiari, V
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Efficacy and safety of dapagliflozin treatment for type 2 diabetes mellitus patients with comorbid cardiovascular disease and hypertension
    Cefalu, W.
    Leiter, L.
    De Bruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S305 - S305
  • [27] The targeted inhibition of neuraminidase reverses endothelial glycocalyx degradation and improves endothelial function in type 2 diabetes
    Foote, Christopher A.
    Ghiarone, Thaysa
    Ramirez-Perez, Francisco I.
    Kluser, Allan R. K.
    Grunewald, Zachary I.
    Jurrissen, Thomas J.
    Brown, Scott M.
    Bender, Shawn B.
    Manrique-Acevedo, Camila
    Aroor, Annayya R.
    Padilla, Jaume
    Martinez-Lemus, Luis A.
    FASEB JOURNAL, 2019, 33
  • [28] Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients with Type 2 Diabetes
    Ang, Lynn
    Kidwell, Kelley M.
    Reiss, Jacob
    Dillon, Brendan R.
    Mizokami-Stout, Kara R.
    Leone, Virginia A.
    Pop-Busui, Rodica
    DIABETES, 2020, 69
  • [29] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes
    Ang, L.
    Kidwell, K.
    Dillon, B.
    Reiss, J.
    Leone, V.
    Mizokami-Stout, K.
    Busui, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S406 - S406
  • [30] Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
    L. N. Broekhuizen
    B. A. Lemkes
    H. L. Mooij
    M. C. Meuwese
    H. Verberne
    F. Holleman
    R. O. Schlingemann
    M. Nieuwdorp
    E. S. G. Stroes
    H. Vink
    Diabetologia, 2010, 53 : 2646 - 2655
12345